Faron is a company headquartered in Finland.
Faron Pharmaceuticals is a clinical-stage biopharmaceutical company developing immunotherapies for cancer, including their lead drug candidate bexmarilimab, which targets myeloid cells to improve cancer treatment efficacy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.